Biotech Values

[DewDiligence]

>I didn't hear the SGP call yet but did Fred say he wants to do a deal in general? …posters on investor village think an HCV one…<

Fred said nothing about a deal in HCV, specifically. However, HCV is a major franchise for SGP and it’s growing long in the tooth (#msg-14167340). So they do need to do something and fairly soon, IMO.

>Why would they be interested in Vertex is their (SGP's) protease inhibitor thought to be that much worse then Vertex's? I would think with Roche having a Polymerase Inhibitor that would be more the area of focus.<

Roche probably was interested in VTRX, as ‘gofish’ mentioned, but now they’re set with ITMN191. If SGP were to acquire VRTX, they could probably divest their own PI relatively easily.

So the combination (SGP+VRTX) does make a lot of sense, IMO. But the impediments (#msg-14169577) are fairly strong too.

Comments?